Glaukos Corporation [clinicaltrials_resource:f1743daf01b424954d4f84362b9ace17]
clinicaltrials:NCT00323284A Study of the Trabecular Micro-Bypass Stent in Combination With Cataract Surgery in Open Angle Glaucoma Subjects. [clinicaltrials:NCT00326014]A Study of the Glaukos Trabecular Micro-Bypass Stent in Refractory Open Angle Glaucoma Subjects [clinicaltrials:NCT00326040]A Study of the iStent in Combo With Cataract Surgery in Newly Diagnosed Open Angle Glaucoma or OH Patients. [clinicaltrials:NCT00326066]A Study of the Glaukos Trabecular Micro-bypass Stent in Open Angle Glaucoma Subjects 1 Stent Versus 2 [clinicaltrials:NCT00326079]clinicaltrials:NCT00721968A Prospective, Unmasked Evaluation of the iStent in Patients With Primary Open-Angle Glaucoma [clinicaltrials:NCT00911924]Evaluation of the iStent Versus Two Ocular Hypotensive Agents in Patients With Primary Open-angle Glaucoma (POAG) [clinicaltrials:NCT00913029]GTS400 Stent Implantation in Conjunction With Cataract Surgery in Subjects With Open-angle Glaucoma [clinicaltrials:NCT01052558]Purpose of This Study is to Evaluate the Safety and Efficacy of One, Two, or Three iStents for the Reduction of Intraocular Pressure in Open-angle Glaucoma Subjects [clinicaltrials:NCT01252849]Prospective Evaluation of Open-Angle Glaucoma Subjects on One Topical Hypotensive Medication Treated With Two iStents [clinicaltrials:NCT01252862]Prospective Evaluation of Open-angle Glaucoma Subjects on Two Topical Hypotensive Medication Treated With Two iStents [clinicaltrials:NCT01252888]A Prospective Evaluation of Open-Angle Glaucoma Subjects on Two Topical Hypotensive Medications Treated With One Suprachoroidal Stent [clinicaltrials:NCT01252914]Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent)or Travoprost [clinicaltrials:NCT01443988]clinicaltrials:NCT01444040Open-angle Glaucoma Subjects on One Ocular Hypotensive Medication Randomized to Treatment With Two Trabecular Micro-bypass Stents or Selective Laser Trabeculoplasty [clinicaltrials:NCT01444105]Open-angle Glaucoma Subjects on One Topical Hypotensive Medication Randomized to Treatment With One or Two Trabecular Micro-bypass Stents in Conjunction With Cataract Surgery [clinicaltrials:NCT01455467]Open-Angle Glaucoma Subjects With One Prior Trabeculectomy Treated Concurrently With One Suprachoroidal Stent and Two Trabecular Micro-bypass Stents [clinicaltrials:NCT01456390]Multicenter Investigation of the Glaukos® Suprachoroidal Stent Model G3 In Conjunction With Cataract Surgery [clinicaltrials:NCT01461278]Multicenter Study Using Glaukos® Trabecular Micro-Bypass Stent Model GTS400 Using the G2-M-IS Injector System in Conjunction With Cataract Surgery [clinicaltrials:NCT01461291]Safety and Efficacy of One, Two, or Three iStents for the Reduction of Intraocular Pressure in Open-angle Glaucoma Subjects [clinicaltrials:NCT01517477]Post-approval Study of The Glaukos® iStent® Trabecular Micro-bypass Stent: Extended Follow-up of the Premarket Cohort [clinicaltrials:NCT01836042]Glaukos® iStent® Trabecular Micro-Bypass Stent System In Conjunction With Cataract Surgery Postmarket Registry [clinicaltrials:NCT01841437]clinicaltrials:NCT01841450Multicenter Investigation of Trabecular Micro-Bypass Stents vs. Laser Trabeculoplasty [clinicaltrials:NCT02327312]
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
organization [clinicaltrials_vocabulary:organization]
clinicaltrials:NCT00323284A Study of the Trabecular Micro-Bypass Stent in Combination With Cataract Surgery in Open Angle Glaucoma Subjects. [clinicaltrials:NCT00326014]A Study of the Glaukos Trabecular Micro-Bypass Stent in Refractory Open Angle Glaucoma Subjects [clinicaltrials:NCT00326040]A Study of the iStent in Combo With Cataract Surgery in Newly Diagnosed Open Angle Glaucoma or OH Patients. [clinicaltrials:NCT00326066]A Study of the Glaukos Trabecular Micro-bypass Stent in Open Angle Glaucoma Subjects 1 Stent Versus 2 [clinicaltrials:NCT00326079]clinicaltrials:NCT00721968A Prospective, Unmasked Evaluation of the iStent in Patients With Primary Open-Angle Glaucoma [clinicaltrials:NCT00911924]Evaluation of the iStent Versus Two Ocular Hypotensive Agents in Patients With Primary Open-angle Glaucoma (POAG) [clinicaltrials:NCT00913029]GTS400 Stent Implantation in Conjunction With Cataract Surgery in Subjects With Open-angle Glaucoma [clinicaltrials:NCT01052558]Purpose of This Study is to Evaluate the Safety and Efficacy of One, Two, or Three iStents for the Reduction of Intraocular Pressure in Open-angle Glaucoma Subjects [clinicaltrials:NCT01252849]Prospective Evaluation of Open-Angle Glaucoma Subjects on One Topical Hypotensive Medication Treated With Two iStents [clinicaltrials:NCT01252862]Prospective Evaluation of Open-angle Glaucoma Subjects on Two Topical Hypotensive Medication Treated With Two iStents [clinicaltrials:NCT01252888]A Prospective Evaluation of Open-Angle Glaucoma Subjects on Two Topical Hypotensive Medications Treated With One Suprachoroidal Stent [clinicaltrials:NCT01252914]Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent)or Travoprost [clinicaltrials:NCT01443988]clinicaltrials:NCT01444040Open-angle Glaucoma Subjects on One Ocular Hypotensive Medication Randomized to Treatment With Two Trabecular Micro-bypass Stents or Selective Laser Trabeculoplasty [clinicaltrials:NCT01444105]Open-angle Glaucoma Subjects on One Topical Hypotensive Medication Randomized to Treatment With One or Two Trabecular Micro-bypass Stents in Conjunction With Cataract Surgery [clinicaltrials:NCT01455467]Open-Angle Glaucoma Subjects With One Prior Trabeculectomy Treated Concurrently With One Suprachoroidal Stent and Two Trabecular Micro-bypass Stents [clinicaltrials:NCT01456390]Multicenter Investigation of the Glaukos® Suprachoroidal Stent Model G3 In Conjunction With Cataract Surgery [clinicaltrials:NCT01461278]Multicenter Study Using Glaukos® Trabecular Micro-Bypass Stent Model GTS400 Using the G2-M-IS Injector System in Conjunction With Cataract Surgery [clinicaltrials:NCT01461291]Safety and Efficacy of One, Two, or Three iStents for the Reduction of Intraocular Pressure in Open-angle Glaucoma Subjects [clinicaltrials:NCT01517477]Post-approval Study of The Glaukos® iStent® Trabecular Micro-bypass Stent: Extended Follow-up of the Premarket Cohort [clinicaltrials:NCT01836042]Glaukos® iStent® Trabecular Micro-Bypass Stent System In Conjunction With Cataract Surgery Postmarket Registry [clinicaltrials:NCT01841437]clinicaltrials:NCT01841450Multicenter Investigation of Trabecular Micro-Bypass Stents vs. Laser Trabeculoplasty [clinicaltrials:NCT02327312]
source [clinicaltrials_vocabulary:source]
Glaukos Corporation [clinicaltrials_resource:f1743daf01b424954d4f84362b9ace17]
Bio2RDF identifier
f1743daf01b424954d4f84362b9ace17
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:f1743daf01b424954d4f84362b9ace17
organization [clinicaltrials_vocabulary:organization]
identifier
clinicaltrials_resource:f1743daf01b424954d4f84362b9ace17
title
Glaukos Corporation
@en
type
label
Glaukos Corporation [clinicaltrials_resource:f1743daf01b424954d4f84362b9ace17]
@en